Indazole compounds, pharmaceutical compositions, and methods...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

06919461

ABSTRACT:
Indazole compounds that modulate and/or inhibit cell proliferation, such as the activity of protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating, e.g., kinases-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

REFERENCES:
“Some derivatives of 5-nitro and 5-amino-3-indazolecarboxylic acid”, Zh. Obshch. Khim., vol. 31, pp. 3255-3257, 1961.
Greene et. al., Protective Groups in Organic Synthesis, Wiley & Sons, Inc., p. 537.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indazole compounds, pharmaceutical compositions, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazole compounds, pharmaceutical compositions, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compounds, pharmaceutical compositions, and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3426059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.